Funder: National Institutes of Health
Due Dates: June 16, 2026 (Forecasted)
Funding Amounts: Estimated total program funding: $1,600,000 | Expected number of awards: 2
Summary: Supports development, validation, and demonstration of advanced 3-D tissue models for drug screening to accelerate therapeutic discovery.
Key Information: Applicants must use NCATS 3-D Bioprinting laboratory resources; clinical trials are not allowed.